Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America-Reference-Cited by-同舟云学术

Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America

Published:2019-05-24 Issue:2 Volume:8 Page:207-214
ISSN:2193-8253
Container-title:Neurology and Therapy
language:en
Short-container-title:Neurol Ther

Author:

Steinberg Judith,Fragoso Yara D.^ORCID,Duran Quiroz Juan Carlos,García Juan Raul,Guerra Caroline,Rodriguez Virginia,Carcamo Rodriguez Claudia,Ciampi Ethel,Correa-Diaz Edgar,Macías Miguel,Novarro Nelson,Vizcarra Darwin,Oehninger Gatti Carlos,Orozco Geraldine,Carrá Adriana

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s40120-019-0139-y.pdf

Reference12 articles.

1. Kwon O, Joung J, Park Y, Kim CW, Hong SH. Considerations of critical quality attributes in the analytical comparability assessment of biosimilar products. Biologicals. 2017;48:101–8. https://doi.org/10.1016/j.biologicals.2017.04.005 .

2. Olech E. Biosimilars: rationale and current regulatory landscape. Semin Arthritis Rheum. 2016;45(5 Suppl):S1–10. https://doi.org/10.1016/j.semarthrit.2016.01.001 .

3. Declerck P, Farouk-Rezk M, Rudd PM. Biosimilarity versus manufacturing change: two distinct concepts. Pharm Res. 2016;33(2):261–8. https://doi.org/10.1007/s11095-015-1790-3 .

4. Garcia R, Araujo DV. The regulation of biosimilars in Latin America. Curr Rheumatol Rep. 2016;18(3):16. https://doi.org/10.1007/s11926-016-0564-1 .

5. Pineda C, Caballero-Uribe CV, Oliveira MG, et al. Recommendations on how to ensure the safety and effectiveness of biosimilars in Latin America: a point of view. Clin Rheumatol. 2015;34(4):635–40. https://doi.org/10.1007/s10067-015-2887-02015 .

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generic MS medications: Reducing costs without compromising safety;Multiple Sclerosis Journal;2022-11-07

2. Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations;Multiple Sclerosis Journal;2022-08-24

3. Practical issues concerning the use of Magnetic Resonance Imaging in Multiple Sclerosis in Latin America: Discussion from 16 centres on behalf of the Foro Latam EM Study Group;Multiple Sclerosis and Related Disorders;2022-03

4. Adverse events and monitoring requirements associated with monoclonal antibody therapy in patients with multiple sclerosis;Drugs & Therapy Perspectives;2019-10-19

5. Biosimilars and the Patent Law;MED LAW SOC;2019